Hyperfractionated radiotherapy of human tumors: Overview of the randomized clinical trials
- 1 January 1997
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 37 (2), 259-267
- https://doi.org/10.1016/s0360-3016(96)00511-1
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- 321 Hyperfractionated (HF) and accelerated (AF) radiotherapy (RT) in head and neck cancers: Facts from trials, impact on standard practiceEuropean Journal Of Cancer, 1995
- Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1995
- 109 RTOG 8808 ECOG 4588, preliminary analysis of a phase III trial in regionally advanced unresectable now small cell lung cancer with minimum three year follow-upInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Radiotherapy of the rhabdomyosarcoma R1H of the rat: Hyperfractionation—126 fractions applied within 6 weeksInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Response of human tumour xenografts to fractionated X-irradiationRadiotherapy and Oncology, 1986
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Superfractionation radiation therapy in the treatment of malignant astrocytomaCancer, 1983
- Malignant astrocytoma. Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trialCancer, 1982
- Effects of irradiation by single or multiple fractions per day on a transplantable murine mammary carcinomaThe British Journal of Radiology, 1982
- A method for assessing the quality of a randomized control trialControlled Clinical Trials, 1981